1759-4774
Monthly
No
NAT REV CLIN ONCOL
2009
45
ENGLAND
http://www.nature.com/nrclinonc/index.html
較慢,6-12周審稿時間
很難平均錄用比例
34.106影響因子
腫瘤學(xué)小學(xué)科
《自然評論》的臨床內(nèi)容由國際知名的臨床學(xué)者和研究人員撰寫,面向醫(yī)學(xué)科學(xué)領(lǐng)域的讀者,從研究生水平向上。我們的目標(biāo)是讓從事某一專業(yè)的醫(yī)生、研究人員和學(xué)者閱讀,但我們的目標(biāo)是讓從事任何醫(yī)學(xué)學(xué)科的讀者都能閱讀到我們所有的文章。深入回顧當(dāng)前關(guān)于某一主題的權(quán)威、最新信息,將其置于某一領(lǐng)域的歷史和發(fā)展背景中。專題討論和意見在觀點(diǎn)和新聞與觀點(diǎn)文章中提供,在研究重點(diǎn)部分,我們從一系列專業(yè)和一般醫(yī)學(xué)期刊中篩選初步研究。涵蓋的主題化療臨床藥理學(xué)診斷流行病學(xué)實(shí)驗(yàn)療法遺傳學(xué)衛(wèi)生服務(wù)、經(jīng)濟(jì)學(xué)和成果研究血液學(xué)激素療法成像免疫療法腫瘤學(xué)緩和醫(yī)療病理兒科腫瘤學(xué)預(yù)防放射治療科篩選信號轉(zhuǎn)導(dǎo)統(tǒng)計(jì)外科腫瘤學(xué)靶向治療
http://mts-nrclinonc.nature.com/cgi-bin/main.plex
Nature Reviews' clinical content is written by internationally renowned clinical academics and researchers and targeted towards readers in the medical sciences, from postgraduate level upwards. While intended to be read by practicing doctors, researchers and academics within a specialty, we aim to make all our articles accessible to readers working in any medical discipline.In-depth Reviews present authoritative, up-to-date information on a topic, placing it in the context of a field's history and development. Topical discussion and opinions are proffered in Perspectives and News & Views articles, and in the Research Highlights section we filter primary research from a range of specialty and general medical journals.Subjects CoveredChemotherapyClinical pharmacologyDiagnosisEpidemiologyExperimental therapiesGeneticsHealth services, economics and outcomes researchHematologyHormonal therapiesImagingImmunotherapyMedical oncologyPalliative carePathologyPediatric oncologyPreventionRadiotherapyScreeningSignal transductionStatisticsSurgical oncologyTargeted therapies
快速預(yù)審、投刊前指導(dǎo)、專業(yè)學(xué)術(shù)評審,對文章進(jìn)行評價;
立即咨詢校對編輯、深度潤色,讓稿件符合學(xué)術(shù)規(guī)范,格式體例等標(biāo)準(zhǔn);
立即咨詢適用于語句和結(jié)構(gòu)尚需完善和調(diào)整的中文文章,確保稿件達(dá)到要求;
立即咨詢數(shù)據(jù)庫包括:期刊、文章、書籍、會議、預(yù)印書、百科全書和摘要等;
立即咨詢讓作者在期刊選擇時避免走彎路,縮短稿件被接收的周期;
立即咨詢根據(jù)目標(biāo)期刊格式要求對作者文章進(jìn)行全面的格式修改和調(diào)整;
立即咨詢幫助作者將稿件提交至目標(biāo)期刊投稿系統(tǒng),降低退稿或拒稿率;
立即咨詢按照您提供的稿件內(nèi)容,指導(dǎo)完成投稿附信(cover letter);
立即咨詢大類學(xué)科同領(lǐng)域優(yōu)質(zhì)期刊 | 大類學(xué)科 | 小類學(xué)科 | 影響因子 | 分區(qū) | ISSN |
---|---|---|---|---|---|
ACTA ONCOLOGICA | 醫(yī)學(xué) | 腫瘤學(xué) | 3.298 | 3區(qū) | 0284-186X |
Advances in Cancer Research | 醫(yī)學(xué) | 腫瘤學(xué) | 4.667 | N/A | 0065-230X |
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 醫(yī)學(xué) | 腫瘤學(xué) | 3.015 | N/A | 0277-3732 |
ANNALS OF ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 14.196 | N/A | 0923-7534 |
ANNALS OF SURGICAL ONCOLOGY | 醫(yī)學(xué) | 腫瘤學(xué) | 3.681 | N/A | 1068-9265 |
ANTI-CANCER DRUGS | 醫(yī)學(xué) | 腫瘤學(xué) | 1.801 | N/A | 0959-4973 |
ANTICANCER RESEARCH | 醫(yī)學(xué) | 腫瘤學(xué) | 1.935 | N/A | 0250-7005 |
Asia-Pacific Journal of Clinical Oncology | 醫(yī)學(xué) | 腫瘤學(xué) | 1.539 | N/A | 1743-7555 |
BMC CANCER | 醫(yī)學(xué) | 腫瘤學(xué) | 2.933 | N/A | 1471-2407 |
Brachytherapy | 醫(yī)學(xué) | 腫瘤學(xué) | 2.03 | 4區(qū) | 1538-4721 |
發(fā)現(xiàn)心儀選題請?zhí)顔?/b>
獲取發(fā)表周期短、審稿速度快容易錄用的期刊